About NovaVision
NovaVision is a publicly listed company based in Boca Raton (United States) founded in 2003. Non-invasive devices are developed for vision restoration in stroke survivors. It operates on a HealthTech and Subscription Services model. NovaVision has raised $38 million across 3 funding rounds from investors including Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors. NovaVision has completed 1 acquisition, including Sight Science. NovaVision offers products and services including Vision Restoration Therapy (VRT) and NeuroEyeCoach. Its focus areas include Medical Devices and Vision Rehabilitation. Its legal entity is NovaVision Inc. Its competitors include Sight Science, EnClear Therapies and AccuMedical; 3 of its 3 listed competitors have raised funding.
Company details
NovaVision is engaged in providing therapies for vision loss caused by neurological conditions such as stroke or brain injury. Solutions are offered in the healthcare sector, specifically targeting vision rehabilitation. Two primary therapies, Vision Restoration Therapy (VRT) and NeuroEyeCoach, are developed to help patients recover and adapt to vision impairments. These evidence-based programs are supported by scientific research and clinical studies, aiming to improve patients quality of life through innovative treatment options.
- Headquarters Boca Raton, United States
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website novavision.com
- Social LinkedIn X Facebook
- Legal Name Novavision Inc.
- Total Equity Funding$38M (USD)
in 3 rounds
- Latest Funding Round$20M (USD), Series C
Jan 2007
- InvestorsJohnson & Johnson Innovation – JJDC
& 4 more
- Investments & Acquisitions
Products & Services of NovaVision
NovaVision offers a comprehensive portfolio of products and services, including Vision Restoration Therapy (VRT) and NeuroEyeCoach.
Therapy is designed to restore vision post-injury.
Program is developed to improve eye movement efficiency.
Funding Insights of NovaVision
NovaVision has successfully raised a total of $38M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $38M
- Total Rounds 3
- Last Round Series C — $20M
- First Round $6M
(Sep 2003)
- Investors Count 5
All 3 funding rounds of NovaVision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $20M | Series C | – | – | |
| Feb 2005 | $12M | Series B | – | – | |
| Sep 2003 | $6M | Series A | – | – |
5 investors in total: 5 institutional.
Investors in NovaVision
NovaVision has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
Growth stage VC fund investing in the US, Europe and Canada | oakwoodmedical.com | St. Louis, United States | ||
Healthcare investments are made by Tullis Health Investors. | tullisfunds.com | Palm Beach Gardens, United States | ||
Tech and Life Sciences focused VC firm investing in the US | noromoseley.com | Atlanta, United States | ||
| crossbowventures.com |
Investor details for NovaVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NovaVision
3 people are tracked at NovaVision (1 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Navroze Mehta | President & CEO | Leadership |
Charles Beard | Client Relationship Manager | Team |
Stephan von Schilcher | Business Development Manager | Team |
Complete people profiles for NovaVision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovaVision
NovaVision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sight Science.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Visual rehabilitation for brain-injured patients with field loss is provided. | sightscience.com | Shoreview, United States | 2006 | Jan 2012 | •••• |
Complete acquisition details for NovaVision
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NovaVision
4 dated milestones of NovaVision across 9 years, from founding to its latest funding, stage changes and deals.
- Founded NovaVision is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series C, of $20.0M.
- Acquisition Acquires Sight Science.
Competitors of NovaVision
NovaVision has 3 listed competitors in our database, 3 of them funded. They include Sight Science, EnClear Therapies and AccuMedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sightscience.com | 2006 | Shoreview, United States | $7.52M | 204 | Visual rehabilitation for brain-injured patients with field loss is provided. | |
| encleartherapies.com | 2018 | Cambridge, United States | $12.72M | Developer of device-based therapies to treat neurodegenerative disorders | ||
| accumedical.cn | 2016 | Santa Ana, United States | $14.28M | Neurovascular interventional devices for neurological disorders are developed. |
Detailed competitors of NovaVision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NovaVision
The website of NovaVision (novavision.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 24.1% vs previous month
Websites whose visitors overlap most with NovaVision. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
canadiancontactlenses.com | canadiancontactlenses.com | 100% | #498,052 | – | |
covd.org | covd.org | 90% | #830,563 | – | |
ocvt.info | ocvt.info | 89% | #2,990,629 | – | |
aaopt.org | aaopt.org | 88% | #505,768 | – | |
optometryclinic.com | optometryclinic.com | 88% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for NovaVision
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as NovaVision (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novavision
Complete news archive for NovaVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaVision
NovaVision was founded in 2003.
NovaVision is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
NovaVision is a funded company, having raised a total of $38M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Sep 2003.
NovaVision is engaged in providing therapies for vision loss caused by neurological conditions such as stroke or brain injury. Solutions are offered in the healthcare sector, specifically targeting vision rehabilitation. Two primary therapies, Vision Restoration Therapy (VRT) and NeuroEyeCoach, are developed to help patients recover and adapt to vision impairments. These evidence-based programs are supported by scientific research and clinical studies, aiming to improve patients quality of life through innovative treatment options.
NovaVision's top competitors include Sight Science, EnClear Therapies and AccuMedical.
NovaVision offers Vision Restoration Therapy (VRT) and NeuroEyeCoach.
NovaVision has made 1 acquisition, including Sight Science.
NovaVision has 5 investors. Key investors include Johnson & Johnson Innovation – JJDC, Oakwood Medical, Tullis Health Investors, Noro-Moseley Partners, and Crossbow Ventures.
NovaVision operates through Novavision Inc..